Indeed, many of the SAMD9/SAMD9L mutations originally described by our group in pediatric MDS were found in patients with refractory cytopenia of childhood [2], which is predominantly associated with a hypocellular BM phenotype. The gene discussed is SAMD9; the disease is myelodysplastic syndrome.